Rafferty Asset Management »

Arrivent Biopharma shares owned by Rafferty Asset Management

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by Rafferty Asset Management from 13F filings

Historical chart of Rafferty Asset Management investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by Rafferty Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by Rafferty Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $727k 27k 26.64
2024-09-30 $224k 9.5k 23.50

More positions owned by Rafferty Asset Management

Ishares Tr 20 Yr Tr Bd Etf (TLT)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Broadcom (AVGO)
Ishares Tr China Lg-cap Etf (FXI)
Apple (AAPL)
Microsoft Corporation (MSFT)
Advanced Micro Devices (AMD)
Qualcomm (QCOM)
Texas Instruments Incorporated (TXN)
Marvell Technology (MRVL)
Analog Devices (ADI)
Applied Materials (AMAT)
Lam Research Corp Com New (LRCX)

View all positions for Rafferty Asset Management

Top funds holding Arrivent Biopharma

Hillhouse Capital Advisors
OrbiMed Advisors
Suvretta Capital Management
BlackRock
FMR
Octagon Capital Advisors
Sofinnova Ventures
Infinitum Asset Management
Novo A/S
General Catalyst Group Management
Vanguard Group
State Street Corporation
Sc China Holding
Geode Capital Management
Cormorant Asset Management

View all funds holding Arrivent Biopharma